MENU

OTLK Outlook Therapeutics Forecast, Technical & Fundamental Analysis

a manufacturer of biosimilar versions of biopharmaceuticals

Industry Biotechnology
OTLK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
OTLK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

OTLK is expected to report earnings to rise 22.92% to -98 cents per share on May 15

Outlook Therapeutics OTLK Stock Earnings Reports
Q1'24
Est.
$-0.98
Q4'23
Beat
by $0.19
Q3'23
Missed
by $0.94
Q2'23
Missed
by $1.55
Q1'23
Missed
by $0.54
The last earnings report on February 14 showed earnings per share of -80 cents, beating the estimate of -99 cents. With 114.28K shares outstanding, the current market capitalization sits at 126.56M.
A.I. Advisor
published General Information

General Information

a manufacturer of biosimilar versions of biopharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
485 Route 1 South Building F
Phone
+1 609 619-3990
Employees
24
Web
https://www.outlooktherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME21.660.39
+1.83%
GameStop Corp
BTC.X67612.720000571.609400
+0.85%
Bitcoin cryptocurrency
TSLA221.331.76
+0.80%
Tesla
SPY582.302.52
+0.43%
SPDR® S&P 500® ETF Trust
AAPL231.78-2.07
-0.89%
Apple

OTLK and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, OTLK has been loosely correlated with MDGL. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if OTLK jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OTLK
1D Price
Change %
OTLK100%
+1.37%
MDGL - OTLK
37%
Loosely correlated
-0.26%
DNA - OTLK
36%
Loosely correlated
+6.16%
GERN - OTLK
36%
Loosely correlated
-0.48%
HEPA - OTLK
34%
Loosely correlated
+5.41%
CYTK - OTLK
33%
Loosely correlated
-0.18%
More